BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27550734)

  • 1. Protein Markers of Neurotransmitter Synthesis and Release in Postmortem Schizophrenia Substantia Nigra.
    Schoonover KE; McCollum LA; Roberts RC
    Neuropsychopharmacology; 2017 Jan; 42(2):540-550. PubMed ID: 27550734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering the role of the nucleus accumbens in schizophrenia: A postmortem analysis of tyrosine hydroxylase and vesicular glutamate transporters.
    McCollum LA; Roberts RC
    Schizophr Res; 2015 Dec; 169(1-3):369-373. PubMed ID: 26386900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat.
    Bolam JP; Smith Y
    Brain Res; 1990 Oct; 529(1-2):57-78. PubMed ID: 1704287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat.
    Nair-Roberts RG; Chatelain-Badie SD; Benson E; White-Cooper H; Bolam JP; Ungless MA
    Neuroscience; 2008 Apr; 152(4):1024-31. PubMed ID: 18355970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate neurons in the substantia nigra compacta and retrorubral field.
    Yamaguchi T; Wang HL; Morales M
    Eur J Neurosci; 2013 Dec; 38(11):3602-10. PubMed ID: 24102658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia.
    Purves-Tyson TD; Brown AM; Weissleder C; Rothmond DA; Shannon Weickert C
    Mol Brain; 2021 Jun; 14(1):96. PubMed ID: 34174930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2.
    Perreault ML; Fan T; Alijaniaram M; O'Dowd BF; George SR
    PLoS One; 2012; 7(3):e33348. PubMed ID: 22428025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic axons in different divisions of the adult rat striatal complex do not express vesicular glutamate transporters.
    Moss J; Ungless MA; Bolam JP
    Eur J Neurosci; 2011 Apr; 33(7):1205-11. PubMed ID: 21375596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for altered excitatory and inhibitory tone in the post-mortem substantia nigra in schizophrenia.
    Mabry SJ; McCollum LA; Farmer CB; Bloom ES; Roberts RC
    World J Biol Psychiatry; 2020 Jun; 21(5):339-356. PubMed ID: 31062628
    [No Abstract]   [Full Text] [Related]  

  • 10. Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia.
    Rocco BR; Lewis DA; Fish KN
    Biol Psychiatry; 2016 Jun; 79(12):1006-15. PubMed ID: 26364548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification and characterization of GABA-ergic amacrine cells in the retina of GAD67-GFP knock-in mice.
    May CA; Nakamura K; Fujiyama F; Yanagawa Y
    Acta Ophthalmol; 2008 Jun; 86(4):395-400. PubMed ID: 17995983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infusions of tyrosine hydroxylase antisense oligodeoxynucleotide into substantia nigra of the rat: effects on tyrosine hydroxylase mRNA and protein content, striatal dopamine release and behaviour.
    Skutella T; Schwarting RK; Huston JP; Sillaber I; Probst JC; Holsboer F; Spanagel R
    Eur J Neurosci; 1997 Feb; 9(2):210-20. PubMed ID: 9058042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia.
    Rice MW; Roberts RC; Melendez-Ferro M; Perez-Costas E
    Brain Struct Funct; 2016 Jan; 221(1):185-201. PubMed ID: 25269834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [COMPARATIVE STUDY OF NIGROSTRIATAL SYSTEMS IN WISTAR RATS AND RATS PRONE TO SEIZURES].
    Dorofeeva NA; Glazova MV; Khudik KA; Nikitina LS; Kirillova D; Chernigovskaya EV
    Zh Evol Biokhim Fiziol; 2015; 51(3):204-13. PubMed ID: 26281223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of glutamatergic, GABAergic, and glycinergic neurons in the auditory pathways of macaque monkeys.
    Ito T; Inoue K; Takada M
    Neuroscience; 2015 Dec; 310():128-51. PubMed ID: 26391919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat midbrain.
    Lipska BK; Lerman DN; Khaing ZZ; Weinberger DR
    Eur J Neurosci; 2003 Dec; 18(11):3097-104. PubMed ID: 14656305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamate neurons within the midbrain dopamine regions.
    Morales M; Root DH
    Neuroscience; 2014 Dec; 282():60-8. PubMed ID: 24875175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.
    Salvatore MF
    J Neurochem; 2014 May; 129(3):548-58. PubMed ID: 24410633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources.
    Omelchenko N; Sesack SR
    Neuroscience; 2007 May; 146(3):1259-74. PubMed ID: 17391856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral effects of unilateral GDNF administration on dopamine- and GABA-regulating proteins in the rat nigrostriatal system.
    Salvatore MF; Gerhardt GA; Dayton RD; Klein RL; Stanford JA
    Exp Neurol; 2009 Sep; 219(1):197-207. PubMed ID: 19460370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.